Free Trial
LON:KNB

Kanabo Group (KNB) Share Price, News & Analysis

Kanabo Group logo
GBX 0.22 0.00 (0.00%)
As of 05/23/2025

About Kanabo Group Stock (LON:KNB)

Key Stats

Today's Range
0.23
0.23
50-Day Range
0.15
0.68
52-Week Range
0.15
2
Volume
N/A
Average Volume
475,295 shs
Market Capitalization
£1.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Kanabo is creating a new standard in the medical cannabis industry by improving the well-being of millions around the world. Its focus is on the distribution of Cannabis-derived products for medical patients, and non-THC products for CBD consumers. Kanabo have conducted extensive R&D in order to develop high-quality Cannabis extract formulas, innovative medical-grade vaporisers, and various non-smoking consumption solutions – making use easy and accessible for anyone in need of treatment. Clinical and validation activities, including safety and efficiency tests, are conducted in Israel – an established leader in the Cannabis industry. The company is selling initial products in Europe already, and is ready to scale up to meet market demands and projected sales and revenues.

Receive KNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kanabo Group and its competitors with MarketBeat's FREE daily newsletter.

KNB Stock News Headlines

Dollar Collapse Warning: Protect Your Wealth NOW
Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Americans are shifting savings out of traditional accounts to protect what they’ve earned. If you’re concerned about inflation, rising debt, or a falling dollar, this free Wealth Protection Kit includes three timely reports to help you prepare for what’s coming next.
Kanabo Grp Plc Regulatory News
Kanabo Grp Plc Share Chat
See More Headlines

KNB Stock Analysis - Frequently Asked Questions

Kanabo Group's stock was trading at GBX 0.90 at the beginning of 2025. Since then, KNB stock has decreased by 75.0% and is now trading at GBX 0.23.
View the best growth stocks for 2025 here
.

Kanabo Group Plc (LON:KNB) issued its quarterly earnings data on Tuesday, October, 1st. The company reported ($0.28) EPS for the quarter. Kanabo Group had a negative trailing twelve-month return on equity of 121.77% and a negative net margin of 717.63%.

Shares of KNB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kanabo Group investors own include BP (BP), Entain (ENT), Lloyds Banking Group (LLOY), Legal & General Group (LGEN), Meta Platforms (META), Piedmont Lithium (PLL) and Alliance Pharma (APH).

Company Calendar

Last Earnings
10/01/2024
Today
5/27/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
Current Symbol
LON:KNB
CIK
N/A
Phone
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-8,181,001.68
Net Margins
-717.63%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.14 million
Cash Flow
GBX 0.12 per share
Price / Cash Flow
1.82
Book Value
GBX 0.93 per share
Price / Book
0.24

Miscellaneous

Free Float
N/A
Market Cap
£1.42 million
Optionable
Not Optionable
Beta
3.04
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (LON:KNB) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners